Several downstream signaling pathways are often activated in various forms of lung cancer, including the PI3K/AKT/mTOR, MAPK/ERK, MEK/ERK, JAK/STAT, NF-κB, and transforming growth factor-beta (TGF-β) signaling pathways 30. Here, AKT1 is linked to lung cancer.